PhotoBioModulation (PBM) Therapeutics
BioMed Photonics uses a FDA cleared, frequency controlled, monochromatic, coherent photonic source to deliver energy to cells. From a non-ionizing wavelength, BioMed Photonics offers a painless, non-invasive way to proliferate embryonic stem cells, increase circulation, decrease inflammation which accelerates the healing process and reduces pain.
FDA CLEARED SINCE 2005
The BioMed Photonic’s PBM Photonics Delivery System was FDA cleared in 2005 and has been used in numerous medically supervised clinical settings. The FDA clearance states that the treaments are prescription therapy and have been proven to reduce pain and accelerate the healing process.
BioMed Photonics Treatment Protocols
The active medium implemented by BioMed Photonics treatment delivery system has been used in medically supervised clinics for over a decade. This photonics delivery system has administered over 100,000 treatments to over 8,000 patients, achieving over a 90% success rate in relieving pain.
Coefficient of Absorption
For over a decade, the BioMed Photonic’s photon delivery method has been perfected by a team of board certified medical professionals and photonics engineers. The wavelength and delivery system is matched specifically to the receptors at the cellular level, with minimal absorption by water, fat, melanin and other soft tissue during the delivery process.
CHAD W. CARTER
President / CEO
DR. MAX NETO PASKIN
Vice President / Business Development
MARCOS E. MUSAFIR, MD
Cheif Medical Director
CALISTO VENDRAME SOBRINHO
Chief Legal Officer
ARYLDO ZOCCANTE CARDOSO
Chief Financial Officer
Director of Manufacturing